IRIS
VERGARO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.037
AS - Asia 13.518
EU - Europa 12.071
SA - Sud America 3.206
AF - Africa 348
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 25
Totale 53.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.892
SG - Singapore 4.742
IT - Italia 3.655
CN - Cina 3.299
RU - Federazione Russa 3.210
BR - Brasile 2.507
VN - Vietnam 1.943
GB - Regno Unito 1.417
BD - Bangladesh 1.046
HK - Hong Kong 933
DE - Germania 831
CA - Canada 754
FR - Francia 507
UA - Ucraina 471
SE - Svezia 385
FI - Finlandia 340
IN - India 300
IE - Irlanda 269
AR - Argentina 250
MX - Messico 248
NL - Olanda 205
TR - Turchia 188
PL - Polonia 183
ID - Indonesia 171
IQ - Iraq 136
ES - Italia 134
ZA - Sudafrica 128
DK - Danimarca 123
EC - Ecuador 123
IL - Israele 119
JP - Giappone 118
PK - Pakistan 101
CO - Colombia 86
AT - Austria 85
VE - Venezuela 63
UZ - Uzbekistan 61
MA - Marocco 58
AE - Emirati Arabi Uniti 55
LT - Lituania 48
PY - Paraguay 47
CL - Cile 45
PE - Perù 36
SA - Arabia Saudita 35
PH - Filippine 34
EG - Egitto 32
MY - Malesia 31
KE - Kenya 29
TN - Tunisia 29
CH - Svizzera 27
CR - Costa Rica 24
UY - Uruguay 23
AZ - Azerbaigian 22
DZ - Algeria 22
EU - Europa 21
BO - Bolivia 20
JO - Giordania 20
NP - Nepal 20
BE - Belgio 19
AU - Australia 18
HN - Honduras 17
DO - Repubblica Dominicana 15
GT - Guatemala 15
RO - Romania 15
AL - Albania 14
JM - Giamaica 14
KZ - Kazakistan 14
CZ - Repubblica Ceca 13
OM - Oman 13
TW - Taiwan 12
NI - Nicaragua 11
TH - Thailandia 11
AM - Armenia 10
GR - Grecia 10
HU - Ungheria 10
IR - Iran 10
PA - Panama 10
SK - Slovacchia (Repubblica Slovacca) 9
BB - Barbados 8
BY - Bielorussia 8
KR - Corea 8
KW - Kuwait 8
LB - Libano 8
MC - Monaco 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
BG - Bulgaria 7
PT - Portogallo 7
SN - Senegal 7
BH - Bahrain 6
CG - Congo 6
ET - Etiopia 6
GE - Georgia 6
HR - Croazia 6
LV - Lettonia 6
MD - Moldavia 6
MK - Macedonia 6
QA - Qatar 6
RS - Serbia 6
SI - Slovenia 6
SV - El Salvador 6
Totale 53.118
Salva come PNG Salva come JPEG
Città #
Dallas 4.562
Singapore 2.487
Ashburn 1.581
San Jose 1.544
Chicago 1.314
Beijing 1.268
Los Angeles 1.101
Hong Kong 876
Ho Chi Minh City 620
Moscow 590
Salt Lake City 554
Southend 540
Milan 539
New York 515
Buffalo 456
Chandler 453
Fairfield 416
Hanoi 383
Houston 348
Woodbridge 334
San Mateo 332
Rome 331
Council Bluffs 328
Tampa 314
Santa Clara 294
Wilmington 289
The Dalles 281
Seattle 277
São Paulo 264
Dublin 259
Elk Grove Village 249
Ann Arbor 243
Cambridge 242
Falls Church 232
Lauterbourg 231
Hefei 222
Boardman 210
Helsinki 209
Ottawa 197
Jacksonville 191
Dearborn 162
Pisa 161
Beauharnois 156
Warsaw 155
Portsmouth 154
Orem 151
Montreal 147
Munich 145
Stevenage 142
Florence 128
Sterling 123
Mexico City 121
Brooklyn 120
Frankfurt am Main 119
Dong Ket 117
Lancaster 116
London 115
Lawrence 107
Tel Aviv 106
Tokyo 100
Denver 99
Phoenix 97
Poplar 95
Amsterdam 93
Toronto 93
Miami 92
Istanbul 91
Atlanta 90
Chennai 87
Johannesburg 86
Rio de Janeiro 86
Stockholm 82
Da Nang 78
Naples 76
Columbus 74
Nuremberg 73
Dulles 72
Bologna 70
Turin 66
Detroit 60
Haiphong 60
Figino 58
Belo Horizonte 57
Manchester 57
Tashkent 56
San Diego 54
Lappeenranta 53
Washington 53
Boston 52
Genoa 52
Turku 51
Kansas City 50
Palermo 49
San Francisco 47
Brasília 46
Baghdad 44
Bari 44
Biên Hòa 44
Charlotte 43
Curitiba 43
Totale 30.994
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.845
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.706
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.581
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 732
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 697
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 619
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 441
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 410
A simple echocardiographic score to rule out cardiac amyloidosis 391
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 380
The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians 372
A simple echocardiographic score to rule out cardiac amyloidosis 364
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 330
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 327
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 316
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 314
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 314
Adrenergic activation in heart failure: blockade or rebalance? 313
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 309
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 308
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 306
Eligibility for vericiguat in a real‐world, contemporary heart failure population 304
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 301
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 301
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 301
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 297
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 295
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 295
[Ten perspectives for research and innovation in cardiac amyloidosis] 294
Screening the health status of people working in a university 294
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 285
How to take arms against central apneas in heart failure 285
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 285
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 282
Sex-related differences in chronic heart failure 281
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 280
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 273
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 273
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 272
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 271
Cardiac light-chain deposition disease relapsing in the transplanted heart 271
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 271
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 269
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 268
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 265
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 264
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 264
RNA-targeting and gene editing therapies for transthyretin amyloidosis 263
Atrial amyloidosis: mechanisms and clinical manifestations 263
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 262
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 262
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 262
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 261
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 261
Valve disease in cardiac amyloidosis: an echocardiographic score 259
null 258
Update sui biomarcatori nello scompenso cardiaco. 258
Disease features and management of cardiomyopathies in women 257
Biomarkers for the diagnosis and management of heart failure: New frontiers 257
null 253
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 247
Biomarkers for the diagnosis and management of heart failure 244
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 244
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 243
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 242
The search for efficient diagnostic and prognostic biomarkers of heart failure 241
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 240
Renin profiling predicts neurohormonal response to sacubitril/valsartan 240
Role of Imaging in Cardiomyopathies 239
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 239
Valvular heart disease in patients with cardiac amyloidosis 238
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 236
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 236
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 236
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 232
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 232
Correction of procedural arterial pseudoaneurysms: Established and novel procedures 232
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 231
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images 229
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 228
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 228
null 228
null 226
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 225
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction 224
Prognostic value of plasma Renin activity in heart failure. 224
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 224
Etiological Treatment of Cardiac Amyloidosis: Standard of Care and Future Directions 223
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 222
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 221
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 221
Cardiac amyloidosis: Innovations in diagnosis and treatment 219
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure 219
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 218
null 218
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis 218
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 217
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 217
Totale 32.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 248.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.938 165 299 80 198 75 69 202 338 142 199 36 135
2022/20231.348 110 112 62 143 166 178 36 120 253 30 83 55
2023/20241.338 76 36 239 102 73 120 105 65 51 75 55 341
2024/202513.829 112 134 492 202 421 496 1.194 2.132 818 2.025 3.144 2.659
2025/202629.663 1.484 4.089 3.967 3.856 2.799 1.809 2.701 1.353 1.812 1.914 2.033 1.846
2026/2027691 691 0 0 0 0 0 0 0 0 0 0 0
Totale 53.560